FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108509183> ?p ?o ?g. }

• W2108509183 endingPage "151" @default.
• W2108509183 startingPage "143" @default.
• W2108509183 abstract "In trachoma control programmes, azithromycin is distributed to treat the strains of chlamydia that cause ocular disease. We aimed to compare the effect of annual versus twice-yearly distribution of azithromycin on infection with these strains.We did a cluster-randomised trial in 24 subdistricts in northern Ethiopia, which we randomly assigned to receive annual or twice-yearly treatment for all residents of all ages. Random assignment was done with the RANDOM and SORT functions of Microsoft Excel. All individuals were offered their assigned treatment of a single, directly observed, oral dose of azithromycin. A 6 week course of topical 1% tetracycline ointment, applied twice daily to both eyes but not directly observed, was offered as an alternative to azithromycin in patients younger than 12 months, and in patients with self-reported pregnancy, with allergy, or who refused azithromycin. Our primary, prespecified outcome was the prevalence of ocular chlamydial infection in a random sample of children aged 0-9 years at baseline and every 6 months for a total of 42 months within sentinel villages. Our analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00322972.Antibiotic coverage of children aged 1-9 years was greater than 80% (range 80·9 to 93·0) at all study visits. In the groups treated annually, the prevalence of infection in children aged 0-9 years was reduced from a mean 41·9% (95% CI 31·5 to 52·2) at baseline to 1·9% (0·3 to 3·5) at 42 months. In the groups treated twice yearly, the prevalence of infection was reduced from a mean 38·3% (29·0 to 47·6) at baseline to 3·2 % (0·0 to 6·5) at 42 months. The prevalence of ocular chlamydial infection in children aged 0-9 years in groups treated annually was not different from that of the groups treated twice yearly at 18, 30, and 42 months (pooled regression p>0·99, 95 % CI -0·06 to 0·06). The mean elimination time in the twice-yearly treatment group was 7·5 months earlier (2·3 to 17·3) than that of the annual group (p=0·10, Cox proportional hazards model).After 42 months of treatment, the prevalence of ocular infection with chlamydia was similar in the groups treated annually and twice yearly. However, elimination of infection might have been more rapid in the groups of villages that received treatment twice yearly.National Institutes of Health (NEI U10 EY016214)." @default.
• W2108509183 created "2016-06-24" @default.
• W2108509183 creator A5003051173 @default.
• W2108509183 creator A5015917731 @default.
• W2108509183 creator A5021420755 @default.
• W2108509183 creator A5025681426 @default.
• W2108509183 creator A5030170309 @default.
• W2108509183 creator A5066526303 @default.
• W2108509183 creator A5069369290 @default.
• W2108509183 creator A5070236238 @default.
• W2108509183 creator A5075952432 @default.
• W2108509183 creator A5077298617 @default.
• W2108509183 creator A5080095497 @default.
• W2108509183 creator A5081280153 @default.
• W2108509183 creator A5085853519 @default.
• W2108509183 creator A5087875655 @default.
• W2108509183 date "2012-01-01" @default.
• W2108509183 modified "2023-09-23" @default.
• W2108509183 title "Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial" @default.
• W2108509183 cites W1919799707 @default.
• W2108509183 cites W1965919358 @default.
• W2108509183 cites W1966714873 @default.
• W2108509183 cites W1971155052 @default.
• W2108509183 cites W1978653163 @default.
• W2108509183 cites W1982556454 @default.
• W2108509183 cites W1989717351 @default.
• W2108509183 cites W2027425022 @default.
• W2108509183 cites W2033558409 @default.
• W2108509183 cites W2034907689 @default.
• W2108509183 cites W2051956817 @default.
• W2108509183 cites W2052896715 @default.
• W2108509183 cites W2059474616 @default.
• W2108509183 cites W2060506754 @default.
• W2108509183 cites W2067312370 @default.
• W2108509183 cites W2087831282 @default.
• W2108509183 cites W2094393529 @default.
• W2108509183 cites W2095264334 @default.
• W2108509183 cites W2111614444 @default.
• W2108509183 cites W2119453208 @default.
• W2108509183 cites W2125790920 @default.
• W2108509183 cites W2129850254 @default.
• W2108509183 cites W2130082558 @default.
• W2108509183 cites W2130937568 @default.
• W2108509183 cites W2134412546 @default.
• W2108509183 cites W2135165654 @default.
• W2108509183 cites W2138904885 @default.
• W2108509183 cites W2141214343 @default.
• W2108509183 cites W2151869728 @default.
• W2108509183 cites W2153465939 @default.
• W2108509183 cites W2156867638 @default.
• W2108509183 cites W2158294771 @default.
• W2108509183 cites W2162905114 @default.
• W2108509183 cites W2164559017 @default.
• W2108509183 cites W4211224178 @default.
• W2108509183 doi "https://doi.org/10.1016/s0140-6736(11)61515-8" @default.
• W2108509183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22192488" @default.
• W2108509183 hasPublicationYear "2012" @default.
• W2108509183 type Work @default.
• W2108509183 sameAs 2108509183 @default.
• W2108509183 citedByCount "77" @default.
• W2108509183 countsByYear W21085091832012 @default.
• W2108509183 countsByYear W21085091832013 @default.
• W2108509183 countsByYear W21085091832014 @default.
• W2108509183 countsByYear W21085091832015 @default.
• W2108509183 countsByYear W21085091832016 @default.
• W2108509183 countsByYear W21085091832017 @default.
• W2108509183 countsByYear W21085091832018 @default.
• W2108509183 countsByYear W21085091832019 @default.
• W2108509183 countsByYear W21085091832020 @default.
• W2108509183 countsByYear W21085091832021 @default.
• W2108509183 countsByYear W21085091832022 @default.
• W2108509183 countsByYear W21085091832023 @default.
• W2108509183 crossrefType "journal-article" @default.
• W2108509183 hasAuthorship W2108509183A5003051173 @default.
• W2108509183 hasAuthorship W2108509183A5015917731 @default.
• W2108509183 hasAuthorship W2108509183A5021420755 @default.
• W2108509183 hasAuthorship W2108509183A5025681426 @default.
• W2108509183 hasAuthorship W2108509183A5030170309 @default.
• W2108509183 hasAuthorship W2108509183A5066526303 @default.
• W2108509183 hasAuthorship W2108509183A5069369290 @default.
• W2108509183 hasAuthorship W2108509183A5070236238 @default.
• W2108509183 hasAuthorship W2108509183A5075952432 @default.
• W2108509183 hasAuthorship W2108509183A5077298617 @default.
• W2108509183 hasAuthorship W2108509183A5080095497 @default.
• W2108509183 hasAuthorship W2108509183A5081280153 @default.
• W2108509183 hasAuthorship W2108509183A5085853519 @default.
• W2108509183 hasAuthorship W2108509183A5087875655 @default.
• W2108509183 hasConcept C126322002 @default.
• W2108509183 hasConcept C142724271 @default.
• W2108509183 hasConcept C164866538 @default.
• W2108509183 hasConcept C168563851 @default.
• W2108509183 hasConcept C176400912 @default.
• W2108509183 hasConcept C187212893 @default.
• W2108509183 hasConcept C199360897 @default.
• W2108509183 hasConcept C203014093 @default.
• W2108509183 hasConcept C2777034029 @default.
• W2108509183 hasConcept C2778907293 @default.
• W2108509183 hasConcept C2780122209 @default.

• next